Vigabatrin Powder, For Solution
Product Images NDC 43598-697

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Vigabatrin (NDC 43598-697). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy�s Laboratories Inc.,, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-a (Figure A)

FDA Label Image

Figure-b (Figure B)

FDA Label Image

Figure-c (Figure C)

FDA Label Image

Figure-d (Figure D)

FDA Label Image

Figure-e (Figure E)

FDA Label Image

Figure-f (Figure F)

FDA Label Image

Figure-g (Figure G)

FDA Label Image

Figure-h (Figure H)

FDA Label Image

Figure-i (Figure I)

FDA Label Image

Figure-j (Figure J)

FDA Label Image

Figure1 (Figure1)

FDA Label Image

Figure2 (Figure2)

FDA Label Image

Mix-1-dose (Mix 1 Dose)

FDA Label Image

Sructure (Sructure)

FDA Label Image

Carton (Carton)

Carton (Carton)
UnVamishatasa is not-available.*
FDA Label Image

Packet (Packet)

FDA Label Image

Syringe-details (Syringe Details)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.